SunTen Phytotech
SunTen Phytotech Co., Ltd. is a Taiwan-based herbal biotechnology subsidiary of Sun Ten Group that develops botanical medicines and functional dietary products, including the FDA IND-cleared cardiovascular drug SB221 and the COVID-19 herbal treatment RespireAid (NRICM101).
- Company typePrivate
- Founded2000
- HeadquartersTaipei, Taiwan
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What SunTen Phytotech does
SunTen Phytotech Co., Ltd. is a Taiwan-based herbal biotechnology company and wholly-owned subsidiary of Sun Ten Group, established in 2000 to develop new botanical drugs derived from traditional Chinese herbal medicine. The company's primary technical focus is on novel botanical pharmaceutical candidates and standardized herbal extracts; its flagship asset is SB221, a novel cardiovascular botanical drug that received U.S. FDA IND clearance in 2008 — a relatively unusual regulatory milestone for a TCM-derived candidate. The company has been recognized by Taiwan's Ministry of Economic Affairs with the Industry Innovation Performance Award (2008) and by the Drug Technology R&D Award in Pharmaceutics (2009) for SB221 development.
The company engages in product development across multiple categories including botanical formulas, single herbs, OTC products, healthy foods, and botanical reference materials. In 2020, SunTen Phytotech participated in the development of RespireAid (NRICM101/臺灣清冠一號), an instant granule herbal formulation for COVID-19, developed with Taiwan's Tri-Service General Hospital and the National Research Institute of Chinese Medicine (NRICM), and notable as the first herbal formula approved to treat COVID-19 in Taiwan. The company has continued to expand its consumer-facing offering with healthy food launches including Instant Ginger Tea (Joyful Series) in February 2023 and All Mightea Plus in 2023.
SunTen Phytotech operates within the broader Sun Ten Group distribution infrastructure, which spans Asia-Pacific, North America, Europe, and Oceania via regional distributor entities. Commercial channels include a multinational distributor network, an Amazon storefront (under the NUWONDER brand), a direct consumer/professional inquiry system, and a "TCM Pro" mobile application on iOS and Android. The company's customer base includes healthcare professionals (Chinese medicine physicians, clinics, acupuncturists, therapists), distributors and store owners, professors and students, and end consumers — but disclosed revenue, pricing, and commercial concentration metrics are not publicly available, and direct revenue attribution within the group's consolidated activities is limited.
SunTen Phytotech firmographics
Firmographics- Name
- SunTen Phytotech
- Legal name
- SunTen Phytotech Co., Ltd.
- Website
- https://suntenglobal.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SunTen Phytotech Co., Ltd. is a Taiwan-based herbal biotechnology subsidiary of Sun Ten Group that develops botanical medicines and functional dietary products, including the FDA IND-cleared cardiovascular drug SB221 and the COVID-19 herbal treatment RespireAid (NRICM101).
- Ownership category
- akta.pro rank
SunTen Phytotech industry classification
Industry- Product category
- Botanical Pharmaceuticals
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts) (AFAJAKAD)
Keywords
Where SunTen Phytotech is headquartered
LocationHeadquarters
- HQ city
- Taipei
- HQ country
- Taiwan
- HQ region
- Asia
Markets served
SunTen Phytotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales
SunTen Phytotech product offering
Product offeringCore offering
SunTen Phytotech develops novel botanical drugs and herbal-based functional dietary products using standardized scientific extraction methods. Its product portfolio spans cardiovascular botanical drug candidates (SB221), clinically validated herbal formulas (RespireAid/NRICM101 for COVID-19), single herbs, OTC formulations, medical devices, healthy food products, and botanical reference materials. The company operates within the Sun Ten Group's vertically integrated value chain from R&D through GMP-certified manufacturing to global distribution.
Differentiator
Problem solved
Functional benefit
Products and services
- SB221 Novel Cardiovascular Botanical Drug
- RespireAid (NRICM101 / 臺灣清冠一號)
- Instant Ginger Tea
- All Mightea Plus
- Botanical Reference Materials (BRM)
- Single Herbs
- Formula Products
- OTC Products
- Medical Devices
Companies that use SunTen Phytotech
Customer profileIdeal customer profiles3 records
SunTen Phytotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
SunTen Phytotech partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Sun Ten Group (Parent)coreSunTen Phytotech Co., Ltd. is established as part of the Sun Ten Group for developing new botanical drugs. The company operates alongside SunTen Pharmaceutical and other group entities to expand into new markets and embrace new opportunities in the natural herbal product segment.
Recent moves6 records
Expansion highlights5 records
SunTen Phytotech competitors and assessment
Company assessmentEmerging players
- Gaia Herbs: U.S.-based vertically integrated herbal supplements company with its own herb farm and extraction operations; comparable in standardized herbal extract philosophy, traceability, and premium botanical positioning.
- Standard Process Inc. U.S.-based whole-food and botanical supplement manufacturer focused on practitioner channel; comparable in standardized botanical extract product development and quality-controlled herbal formulations.
- Himalaya Wellness (Himalaya Drug Company): Global herbal health and wellness company with a botanical R&D and consumer product model directly comparable to SunTen Phytotech's phytotech approach, particularly for healthy-food and herbal supplement categories.
Direct peers
- Sun Ten Natureceutica: Sister company within Sun Ten Group focused on nutraceuticals; directly comparable in botanical extract product development and serves the same consumer and institutional customers across the group's distribution network.
- YFY Biotech Management Company: Taiwan-listed biotech investor and operator focused on biopharmaceutical and plant-based platforms; previously invested in SunTen Phytotech and operates in adjacent botanical/biotech R&D areas.
- KPC Pharmaceuticals, Inc. Taiwan-based GMP manufacturer specializing in traditional Chinese herbal medicines and concentrated herbal extracts; competes directly with SunTen Phytotech for institutional TCM customers and export channels.
- Sun Ten Pharmaceutical Co., Ltd. Parent company and direct operating counterpart within the Sun Ten Group; shares the same TCM herbal extracts and nutraceuticals business, providing the integrated distribution and manufacturing backbone that SunTen Phytotech's products feed into.
- Phytoceutica Inc. U.S.-based botanical venture listed as a strategic alliance partner of Sun Ten Group; comparable as a North American distributor of Chinese botanical extracts serving the same end customer base.
Broad incumbents
- Blackmores Limited: Australia-listed leader in vitamins, herbal, and nutritional supplements with deep Asia-Pacific retail presence; comparable in botanical supplement product range and distribution scale that SunTen Phytotech competes against in export markets.
- Yung Shin Pharmaceutical Industrial Co., Ltd. One of Taiwan's largest GMP pharmaceutical manufacturers with a broad TCM and botanical drug portfolio; competes with SunTen Phytotech across both institutional TCM and consumer healthy-food channels as a larger-scale incumbent.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
SunTen Phytotech social profiles
Digital presenceSunTen Phytotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
SunTen Phytotech leadership team
Management profileNumber of profiles
Profiles2 records
SunTen Phytotech funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SunTen Phytotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SunTen Phytotech
What does SunTen Phytotech do?
SunTen Phytotech develops novel botanical drugs and herbal-based functional dietary products using standardized scientific extraction methods. Its product portfolio spans cardiovascular botanical drug candidates (SB221), clinically validated herbal formulas (RespireAid/NRICM101 for COVID-19), single herbs, OTC formulations, medical devices, healthy food products, and botanical reference materials. The company operates within the Sun Ten Group's vertically integrated value chain from R&D through GMP-certified manufacturing to global distribution.
Is SunTen Phytotech a public or private company?
SunTen Phytotech is a private company. It is classified as corporate owned and is currently operating.
When was SunTen Phytotech founded?
SunTen Phytotech was founded in 2000. It employs 1 to 10 people.
Where is SunTen Phytotech based?
SunTen Phytotech is headquartered in Taipei, Taiwan, in the Asia region.
Who are SunTen Phytotech's main competitors?
Emerging players on record are Gaia Herbs, Standard Process Inc. and Himalaya Wellness (Himalaya Drug Company). Direct peers are Sun Ten Natureceutica, YFY Biotech Management Company, KPC Pharmaceuticals, Inc., Sun Ten Pharmaceutical Co., Ltd. and Phytoceutica Inc.. Broad incumbents are Blackmores Limited and Yung Shin Pharmaceutical Industrial Co., Ltd..
Does SunTen Phytotech have an API?
No public API is recorded for SunTen Phytotech.
What industry is SunTen Phytotech in?
SunTen Phytotech's product category is Botanical Pharmaceuticals. Its primary akta.pro industry code is AFAJAKAD, Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts). Its NAICS code is 325411 and its SIC code is 2833.